AUM $8.00BER 0.44%NAV $170.47Holdings 250Inception Feb 2001
Price Chart
Key Statistics
Previous Close
$170.49Day Range
$169.98$172.28
52-Week Range
$124.94$177.64
Avg Volume
1.4MDividend Yield
0.23%Expense Ratio
0.44%AUM
$8.00BShares Outstanding
46.2METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 86.26% |
| Netherlands | 3.97% |
| Switzerland | 2.31% |
| United Kingdom | 2.01% |
| Denmark | 2.00% |
| Ireland | 0.78% |
| Canada | 0.76% |
| Germany | 0.66% |
| France | 0.49% |
| Other | 0.14% |
| China | 0.13% |
| Australia | 0.09% |
| Belgium | 0.09% |
| Singapore | 0.09% |
| Spain | 0.09% |
| Italy | 0.08% |
| Luxembourg | 0.04% |
| Taiwan | 0.01% |
Fund Information
- Issuer
- iShares
- Category
- Healthcare
- Types
- Biotech
- Inception Date
- Feb 5, 2001
- Exchange
- NASDAQ
- Description
- The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Similar ETFs
The iShares Biotechnology ETF (IBB) is an exchange-traded fund issued by iShares that launched on Feb 5, 2001. It currently manages $8.00B in assets under management. The fund charges an expense ratio of 0.44%. The fund holds 250 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 45.1% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | AMGN | AMGEN INC | 7.58% | 1,715,110 | $607.3M |
| 2 | VRTX | VERTEX PHARMACEUTICALS INC | 7.45% | 1,339,991 | $596.3M |
| 3 | GILD | GILEAD SCIENCES INC | 7.02% | 4,469,556 | $562.6M |
| 4 | REGN | REGENERON PHARMACEUTICALS INC | 5.73% | 750,116 | $458.7M |
| 5 | ARGX | ARGENX SE ADR | 3.79% | 337,911 | $303.8M |
| 6 | ALNY | ALNYLAM PHARMACEUTICALS INC | 3.50% | 969,089 | $280.4M |
| 7 | BIIB | BIOGEN INC | 2.69% | 1,079,414 | $215.8M |
| 8 | NTRA | NATERA INC | 2.66% | 970,143 | $212.7M |
| 9 | RVMD | REVOLUTION MEDICINES INC | 2.37% | 1,269,798 | $189.5M |
| 10 | ILMN | ILLUMINA INC | 2.27% | 1,095,473 | $182.1M |
| 11 | UTHR | UNITED THERAPEUTICS CORP | 2.13% | 312,101 | $170.2M |
| 12 | INCY | INCYTE CORP | 1.95% | 1,452,092 | $156.6M |
| 13 | INSM | INSMED INC | 1.90% | 1,570,788 | $151.9M |
| 14 | ONC | BEONE MEDICINES AG | 1.70% | 523,577 | $136.3M |
| 15 | MRNA | MODERNA INC | 1.65% | 2,662,884 | $132.2M |
Page 1 of 5
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | +0.16% | |
| 1W | +2.24% | |
| 1M | +2.30% | |
| 3M | +2.11% | |
| 6M | +1.52% | |
| YTD | +0.98% | |
| 1Y | +33.48% | |
| 3Y | +30.89% | |
| 5Y | +7.04% |
Moving Averages
20-Day MA
$168.45
Above 20-Day MA50-Day MA
$170.16
Above 50-Day MA200-Day MA
$163.72
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$177.64
Current Price
$170.77
52-Week Low
$124.94
$124.94$177.64
Current Yield
0.23%
Annual Dividend
$0.4495
Frequency
4x/year
Last Ex-Date
Dec 16, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | $0.1831 | Dec 19, 2025 |
| Sep 16, 2025 | $0.0828 | Sep 19, 2025 |
| Mar 18, 2025 | $0.1212 | Mar 21, 2025 |
| Dec 17, 2024 | $0.0624 | Dec 20, 2024 |
| Sep 25, 2024 | $0.2005 | Sep 30, 2024 |
| Mar 21, 2024 | $0.1260 | Mar 27, 2024 |
| Dec 20, 2023 | $0.1240 | Dec 27, 2023 |
| Sep 26, 2023 | $0.1532 | Oct 2, 2023 |
| Jun 7, 2023 | $0.0062 | Jun 13, 2023 |
| Mar 23, 2023 | $0.0646 | Mar 29, 2023 |
| Dec 13, 2022 | $0.1014 | Dec 19, 2022 |
| Sep 26, 2022 | $0.1586 | Sep 30, 2022 |
| Jun 9, 2022 | $0.0305 | Jun 15, 2022 |
| Mar 24, 2022 | $0.1176 | Mar 30, 2022 |
| Dec 13, 2021 | $0.0413 | Dec 17, 2021 |
| Sep 24, 2021 | $0.1244 | Sep 30, 2021 |
| Jun 10, 2021 | $0.0232 | Jun 16, 2021 |
| Mar 25, 2021 | $0.1311 | Mar 31, 2021 |
| Dec 14, 2020 | $0.0655 | Dec 18, 2020 |
| Sep 23, 2020 | $0.0632 | Sep 29, 2020 |
Dividend Payments Over Time
Category Comparison
| Metric | IBB | Healthcare(176 ETFs) | Biotech(41 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.44% | 0.61% | 0.83% |
| AUM | $8.00B | $910.0M | $1.52B |
| Dividend Yield | 0.23% | 3.35% | 1.97% |
| Avg Volume | 1.4M | 275.1K | 871.8K |
| Holdings | 250 | 99 | 65 |
| Performance | |||
| 1-Month Return | -1.15% | +1.77% | +4.73% |
| 6-Month Return | +1.02% | +3.26% | +5.11% |
| YTD Return | +1.12% | +3.61% | +6.25% |
| 1-Year Return | +33.47% | +24.59% | +37.13% |
Compare with Another ETF
Search for an ETF to compare with IBB:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.